Regarding the tumour-promoting effect of IgA, it has been found that the concentration of IgA is positively correlated with a poor prognosis in both melanoma and HCC [73, 74]; it may regulate the immune function of T cells and cause a decrease in antitumour ability. This evidence concerns the gene CD79A and melanoma.